Thompson Davis & Co., Inc. Halozyme Therapeutics, Inc. Transaction History

Thompson Davis & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$37.35 - $48.3 $338,092 - $437,211	9,052 New	9,052 $398,000
Q4 2021 Feb 14, 2022	SELL	$31.82 - $40.75 $3,977 - $5,093	-125 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$16.87 - $20.3 $4,217 - $5,075	-250 Reduced 66.67%	125 $2,000
Q4 2017 Feb 05, 2018	BUY	$16.75 - $20.8 $4,187 - $5,200	250 Added 200.0%	375 $8,000
Q3 2017 Oct 30, 2017	BUY	$11.76 - $17.4 $1,470 - $2,175	125	125 $2,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.